Ponatinib

Ariad Taking The Fast Track Into Lung Cancer Treatment
Seeking Alpha
Mon, 06/20/16 - 10:14 am
Ariad Pharmaceuticals
fast track
non-small cell lung cancer
Ponatinib
ARIAD Announces Initial Data from Phase 2 Trial of Ponatinib in Patients with Gastrointestinal Stromal Tumors
Yahoo/BusinessWire
Sun, 06/1/14 - 11:36 am
Ponatinib
Ariad Pharmaceuticals
gastrointestinal stromal tumors
ARIAD presents new preclinical data on ponatinib
The Fly on the Wall
Mon, 04/8/13 - 11:38 am
Ariad Pharmaceuticals
Ponatinib
medullary thyroid cancer
non-small cell lung cancer
ARIAD Announces 12-Month Data from Pivotal PACE Trial of Ponatinib in Heavily Pretreated Chronic-Phase CML Patients
Yahoo/BusinessWire
Sun, 12/9/12 - 01:16 pm
Ponatinib
chronic myeloid leukemia
Ariad Pharmaceuticals
FDA Agrees to Speed Review of Ariad Drug
Motley Fool
Fri, 10/26/12 - 11:15 am
FDA
Ariad Pharma
Ponatinib
chronic myeloid leukemia
acute lymphoblastic leukemia
3 Things to Watch at Ariad Pharmaceuticals
Motley Fool
Tue, 10/16/12 - 10:38 am
Ariad Pharmaceuticals
Ponatinib
ridaforolimus
AP1903
AP26113
5 Bio-Pharmas On The Rise With Potential Groundbreaking And Lifesaving Treatments
Seeking Alpha
Tue, 10/9/12 - 04:21 pm
PLX
Pluristem Therapeutics
Ariad Pharmaceuticals
Ponatinib
Sarepta
eteplirsen
Fabry's disease
Amicus Therapeutics
StemCells
ARIAD Pharmaceuticals: Ponatinib Approval Anticipated In Second-Line CML
Seeking Alpha
Mon, 10/1/12 - 11:27 am
Ponatinib
CML
Ariad Pharmaceuticals
Pfizer
Bristol-Myers Squibb
Novartis
This Stock Rocks as Its Drug Rolls Ahead
Motley Fool
Sat, 09/29/12 - 12:11 pm
Ariad Pharmaceuticals
Ponatinib
chronic myelogenous leukemia
leukemia
Ariad Pharmaceuticals Gearing Up For Ponatinib's Approval
Seeking Alpha
Wed, 08/29/12 - 05:54 pm
Ariad Pharmaceuticals
Ponatinib
Pfizer
Bristol-Myers Squibb
Novartis
ARIAD Begins Phase 1/2 Trial of Ponatinib in Japan
Yahoo
Mon, 08/20/12 - 10:33 am
Ariad Pharmaceuticals
Japan
Ponatinib
ASCO '12: Ariad Pharma Leukemia Drug Posts Improved Response Rates
TheStreet.com
Mon, 06/4/12 - 10:58 am
ASCO
Ariad Pharma
leukemia
Ponatinib
ASCO Preview: Eight Cancer Drugs to Watch at the Big Show
Xconomy
Wed, 05/16/12 - 12:27 pm
ASCO
Genentech
T-DM1
breast cancer
tivozanib
Aveo
kidney cancer
Onyx
Bayer
regorafenib
colorectal cancer
Adcetris
Seattle Genetics
JNJ
prostate cancer
Zytiga
cabozantinib
Exelixis
Enzalutamide
Medivation
Ponatinib
chronic myeloid leukemia
Ariad Pharmaceuticals
Top 10 late-stage cancer drugs in 2012
Fierce Biotech
Wed, 04/18/12 - 12:11 pm
BB1608
Boston Biomedical
Dainippon Sumitomo
cabozantinib
Exelixis
ONYX Pharmaceuticals
Carfilzomib
Medivation
Astellas
Enzalutamide
Ariad Pharmaceuticals
Ponatinib
Bayer
regorafenib
Oncovex
Amgen
Roche
Genentech
T-DM1
Immunogen
Aveo
tivozanib
Zaltrap
Sanofi
Regeneron
Ariad leukemia drug helps 47 pct of patients -study
Reuters
Mon, 12/12/11 - 10:46 am
Ariad Pharmaceuticals
Ponatinib
chronic myeloid leukemia
Ariad Pharma: Early Efficacy, Safety of Leukemia Drug 'Striking'
TheStreet.com
Mon, 11/7/11 - 11:00 am
leukemia
Ariad Pharmaceuticals
Ponatinib
10 promising late-stage cancer drugs
Fierce Biotech
Tue, 04/5/11 - 10:47 pm
cancer
Carfilzomib
crizotinib
vismodegib
Oncovex
PLX4032
Ponatinib
SGN-35
tivozanib
T-DM1
cabozantinib
ONYX Pharmaceuticals
Pfizer
Genentech
Curis
Amgen
Plexxikon
Seattle Genetics
Ariad Pharmaceuticals
Aveo Pharmaceutical
Exelixis
Roche